- Home
- YJ vs GLMD Comparison
YJ vs GLMD Comparison
Compare YJ & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YJ | GLMD |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 6.6M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | YJ | GLMD |
|---|---|---|
| Price | $1.29 | $0.85 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.7K | ★ 111.6K |
| Earning Date | 03-20-2026 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,760,127.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.11 | $0.73 |
| 52 Week High | $2.67 | $3.50 |
Technical Indicators
Market Signals| Indicator | YJ | GLMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 43.40 |
| Support Level | $1.11 | $0.73 |
| Resistance Level | $1.31 | $0.88 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 31.01 | 45.93 |
Price Performance
Historical ComparisonAbout YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.